Skip to page body Patient Care Survivorship Research Cancer Types News Giving Community Partners Clinical Trials
UCLA's Jonsson Comprehensive Cancer Center
Take the Jonsson Cancer Center Site Survey

JCCC Member Directory

Mitchell Kamrava, M.D.
Mitchell Kamrava, M.D.

Specialty:

Radiation Oncology

General Information:

Gender:
Male
Language(s):
English, Farsi, Spanish

Affiliation(s):

Assistant Clinical Professor, Department of Radiation Oncology
Member, JCCC Cancer Molecular Imaging Program Area

Hospital Affiliation(s):

Ronald Reagan UCLA Medical Center
UCLA Medical Center, Santa Monica

Education:

Fellowship:
Brachytherapy, UCLA School of Medicine, 2010 - 2011
Residency:
Radiation Oncology, National Cancer Institute, 2006 - 2010
Internship:
Internal Medicine, Stanford University Medical Center, 2005 - 2006
Medical Degree:
M.D., UCSD School of Medicine, 2005

Certification(s):

Board Certification(s):
Radiation Oncology, American Board of Radiology, 2011

Contact Information:

Phone:
(310) 825-9775
Email:
Website:

Practice Information:

Clinical Interest(s):
Gynecologic malignancies
General brachytherapy

Scientific Interest(s):

Dr. Mitchell Kamrava is interested in incorporating multiparametric MRI into radiation treatment planning and investigating its role as a predictive/prognostic imaging marker. He is also active in the validation of serum and urine biomarkers for patients receiving radiation.

Selected Cancer-Related Publications:

Den RB, Kamrava M, Sheng Z, Werner-Wasik M, Dougherty E, Marinucchi M, Lawrence YR, Hegarty S, Hyslop T, Andrews DW, Glass J, Friedman DP, Green MR, Camphausen K, Dicker AP. A phase I study of the combination of sorafenib with temozolomide and radiation therapy for the treatment of primary and recurrent high-grade gliomas. Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):321-8. Epub 2012 Jun 9

Kamrava M, Chung MP, Demarco J, Kayode O, Park SJ, Borja L, Chow L, Lee SP, Steinberg ML, Demanes DJ. Electronic brachytherapy for postsurgical adjuvant vaginal cuff irradiation therapy in endometrial and cervical cancer: a retrospective study. Brachytherapy. 2013 Mar-Apr;12(2):141-7. Epub 2012 Jun 28

White EC, Kamrava MR, Demarco J, Park SJ, Wang PC, Kayode O, Steinberg ML, Demanes DJ. High-dose-rate prostate brachytherapy consistently results in high quality dosimetry. Int J Radiat Oncol Biol Phys. 2013 Feb 1;85(2):543-8. Epub 2012 May 30

Kamrava M, Kesarwala AH, Madan RA, Lita E, Kaushal A, Tsang KY, Poole DJ, Steinberg SM, Ferrara T, Dahut W, Schlom J, Gulley JL. Long-term follow-up of prostate cancer patients treated with vaccine and definitive radiation therapy. Prostate Cancer Prostatic Dis. 2012 Sep;15(3):289-95. Epub 2012 Mar 6

Gulley JL, Madan RA, Tsang KY, Arlen PM, Camphausen K, Mohebtash M, Kamrava M, Schlom J, Citrin D. A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver. Expert Opin Biol Ther. 2011 Nov;11(11):1409-18. Epub 2011 Aug 28